SuperSonic Imagine Receives FDA 510(k) Clearance for Breast- and Liver-Imaging Modes

SuperSonic Imagine Receives FDA 510(k) Clearance for Breast- and Liver-Imaging Modes
SuperSonic Imagine has received 510(k) clearance from the U.S Food and Drug Administration (FDA) for its Aixplorer platform imaging modes, including improved ones for breast imaging. The FDA’s clearance means the company’s new imaging modes, including the Angio PL.U.S. (PlaneWave UltraSensitive Imaging), TriVu, Fusion and Navigation, contrast liver imaging, and B-Mode Ratio, can now be marketed in

Knowledge is power when living with breast cancer.

Get access to the web’s leading Breast Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *